This is the authors' abstract. We don't add key points for this paper.
The concentration of uNGAL can be used in practice as an independent predictor of end stage renal disease among patients with chronic kidney disease, but it may be not useful in predicting disease progression to CKD stage 3 among community-based population.
Answers are grounded in this paper and cite their sources.
No takes yet. Share an insight, caveat, or question.
Zhou et al. (2016) studied this question.
Synapse has enriched 10 related papers. Consider them for comparative context: